Protein Official symbol | NOX1 |
Aliases | NOX1 MOX1 NOH1 |
Chromosomal Location | X |
Length | 564 |
Uniprot ID | Q9Y5S8 |
EC number | 1.-.-.- |
Protein family Information(Pfam) | PF08022;PF01794;PF08030; |
PDB id | None |
InterPro ID | IPR000778;IPR013112;IPR017927;IPR013130;IPR013121;IPR039261;IPR029650;IPR017938; |
dbSNP | rs2071756 rs34688635 rs35404864 |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
NCF2 | NCF1 | 0.9990000000000001 |
NCF1 | CYBA | 0.997 |
NCF2 | CYBA | 0.997 |
NOX1 | CYBA | 0.996 |
NOXO1 | NOXA1 | 0.995 |
NCF4 | CYBA | 0.9940000000000001 |
NOX1 | NOXA1 | 0.993 |
NOXA1 | NCF1 | 0.991 |
NOXO1 | CYBA | 0.99 |
NCF2 | RAC2 | 0.9890000000000001 |
NOX1 | NCF1 | 0.986 |
NOXO1 | NOX1 | 0.986 |
NCF4 | RAC2 | 0.985 |
NCF1 | RAC2 | 0.9840000000000001 |
NCF4 | NCF2 | 0.98 |
NOXA1 | CYBA | 0.9790000000000001 |
NOX1 | NCF2 | 0.977 |
CYBA | RAC2 | 0.9740000000000001 |
RAC1 | NOXA1 | 0.972 |
NCF4 | NCF1 | 0.972 |
RAC1 | NCF1 | 0.9690000000000001 |
NCF2 | RAC1 | 0.961 |
RAC1 | CYBA | 0.953 |
NOXO1 | RAC1 | 0.95 |
NCF4 | NOX1 | 0.946 |
NCF4 | RAC1 | 0.9440000000000001 |
NOXO1 | NCF2 | 0.943 |
NOX1 | DECR1 | 0.9390000000000001 |
NOX1 | RAC1 | 0.935 |
NOX1 | RAC2 | 0.9229999999999999 |
NCF4 | NOXA1 | 0.9229999999999999 |
NCF1 | DECR1 | 0.92 |
NOXO1 | NCF4 | 0.919 |
NCF2 | NOXA1 | 0.9179999999999999 |
RAC1 | RAC2 | 0.9059999999999999 |
# | 4688 (NCF2) | 653361 (NCF1) | 27035 (NOX1) | 124056 (NOXO1) | 4689 (NCF4) | 10811 (NOXA1) | 1535 (CYBA) | 5879 (RAC1) | 5880 (RAC2) | 1666 (DECR1) |
---|---|---|---|---|---|---|---|---|---|---|
4688 (NCF2) | 1.00 | 0.66 | 0.52 | 0.64 | 0.60 | 0.67 | 0.80 | 0.63 | 0.15 | 0.24 |
653361 (NCF1) | 0.66 | 1.00 | 0.55 | 0.80 | 0.72 | 0.70 | 0.79 | 0.51 | 0.24 | 0.36 |
27035 (NOX1) | 0.52 | 0.55 | 1.00 | 0.51 | 0.45 | 0.62 | 0.65 | 0.54 | 0.39 | 0.48 |
124056 (NOXO1) | 0.64 | 0.80 | 0.51 | 1.00 | 0.83 | 0.80 | 0.59 | 0.64 | 0.27 | 0.26 |
4689 (NCF4) | 0.60 | 0.72 | 0.45 | 0.83 | 1.00 | 0.74 | 0.57 | 0.55 | 0.19 | 0.21 |
10811 (NOXA1) | 0.67 | 0.70 | 0.62 | 0.80 | 0.74 | 1.00 | 0.67 | 0.66 | 0.15 | 0.18 |
1535 (CYBA) | 0.80 | 0.79 | 0.65 | 0.59 | 0.57 | 0.67 | 1.00 | 0.58 | 0.15 | 0.36 |
5879 (RAC1) | 0.63 | 0.51 | 0.54 | 0.64 | 0.55 | 0.66 | 0.58 | 1.00 | 1.00 | 0.24 |
5880 (RAC2) | 0.15 | 0.24 | 0.39 | 0.27 | 0.19 | 0.15 | 0.15 | 1.00 | 1.00 | 0.46 |
1666 (DECR1) | 0.24 | 0.36 | 0.48 | 0.26 | 0.21 | 0.18 | 0.36 | 0.24 | 0.46 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOX1 | Human | Blood | - | 3250 m | 4 day | upregulated | 3.6 | Microarray | Himalayas | Indians | 1 | Sea level healthy individuals | 24465776 |
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|
ID | GO ID | GO Term | GO Type |
---|---|---|---|
27035 | GO:0008284 | positive regulation of cell proliferation | GOTERM_BP_DIRECT |
27035 | GO:0005769 | early endosome | GOTERM_CC_DIRECT |
27035 | GO:0030171 | pyridoxal phosphate binding | GOTERM_MF_DIRECT |
27035 | GO:0001525 | angiogenesis | GOTERM_BP_DIRECT |
27035 | GO:0051454 | intracellular pH elevation | GOTERM_BP_DIRECT |
27035 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | GOTERM_BP_DIRECT |
27035 | GO:0055114 | oxidation-reduction process | GOTERM_BP_DIRECT |
27035 | GO:0043020 | NADPH oxidase complex | GOTERM_CC_DIRECT |
27035 | GO:0008217 | regulation of blood pressure | GOTERM_BP_DIRECT |
27035 | GO:0045730 | respiratory burst | GOTERM_BP_DIRECT |
27035 | GO:0046330 | positive regulation of JNK cascade | GOTERM_BP_DIRECT |
27035 | GO:0005515 | protein binding | GOTERM_MF_DIRECT |
27035 | GO:0050661 | flavin adenine dinucleotide binding | GOTERM_MF_DIRECT |
27035 | GO:0071438 | invadopodium membrane | GOTERM_CC_DIRECT |
27035 | GO:0016477 | cell migration | GOTERM_BP_DIRECT |
27035 | GO:0034765 | regulation of ion transmembrane transport | GOTERM_BP_DIRECT |
27035 | GO:0042554 | superoxide anion generation | GOTERM_BP_DIRECT |
27035 | GO:0046872 | metal ion binding | GOTERM_MF_DIRECT |
27035 | GO:0005886 | plasma membrane | GOTERM_CC_DIRECT |
27035 | GO:0006954 | inflammatory response | GOTERM_BP_DIRECT |
27035 | GO:0007165 | signal transduction | GOTERM_BP_DIRECT |
27035 | GO:0072592 | oxygen metabolic process | GOTERM_BP_DIRECT |
27035 | GO:0030054 | cell junction | GOTERM_CC_DIRECT |
27035 | GO:0015992 | proton transport | GOTERM_BP_DIRECT |
27035 | GO:0016175 | phospholipase activator activity | GOTERM_MF_DIRECT |
27035 | GO:0006801 | superoxide metabolic process | GOTERM_BP_DIRECT |
27035 | GO:0071455 | cellular response to hyperoxia | GOTERM_BP_DIRECT |
27035 | GO:0048365 | calcium-dependent protein binding | GOTERM_MF_DIRECT |
27035 | GO:0016021 | integral component of membrane | GOTERM_CC_DIRECT |
27035 | GO:0048661 | positive regulation of smooth muscle cell proliferation | GOTERM_BP_DIRECT |
27035 | GO:1990451 | cellular stress response to acidic pH | GOTERM_BP_DIRECT |
27035 | GO:0006739 | NADP metabolic process | GOTERM_BP_DIRECT |
27035 | GO:0010575 | positive regulation of vascular endothelial growth factor production | GOTERM_BP_DIRECT |
27035 | GO:0042743 | hydrogen peroxide metabolic process | GOTERM_BP_DIRECT |
27035 | GO:0045726 | positive regulation of integrin biosynthetic process | GOTERM_BP_DIRECT |
27035 | GO:0030198 | extracellular matrix organization | GOTERM_BP_DIRECT |
27035 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | GOTERM_BP_DIRECT |
Human Entrez ID | KEGG ID | KEGG Term |
---|---|---|
27035 | hsa04380 | Osteoclast differentiation |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
NOX1 | 27035 | Colonic Neoplasms | C0009375 | Neoplastic Process | 0.31 | 0.607 | 0.586 | group |
NOX1 | 27035 | Left-Sided Heart Failure | C0023212 | Disease or Syndrome | 0.3 | 0.607 | 0.586 | disease |
NOX1 | 27035 | Hypercholesterolemia | C0020443 | Disease or Syndrome | 0.3 | 0.607 | 0.586 | disease |
NOX1 | 27035 | Myocardial Failure | C1959583 | Disease or Syndrome | 0.3 | 0.607 | 0.586 | disease |
NOX1 | 27035 | Congestive heart failure | C0018802 | Disease or Syndrome | 0.3 | 0.607 | 0.586 | disease |
NOX1 | 27035 | Heart Decompensation | C1961112 | Pathologic Function | 0.3 | 0.607 | 0.586 | phenotype |
NOX1 | 27035 | Heart failure | C0018801 | Disease or Syndrome | 0.3 | 0.607 | 0.586 | disease |
NOX1 | 27035 | Malignant tumor of colon | C0007102 | Neoplastic Process | 0.36 | 0.607 | 0.586 | disease |
NOX1 | 27035 | Heart Failure, Right-Sided | C0235527 | Disease or Syndrome | 0.3 | 0.607 | 0.586 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|